CAM

Cormorant Asset Management Portfolio holdings

AUM $1.34B
This Quarter Return
+27.21%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$1.15B
AUM Growth
+$1.15B
Cap. Flow
+$129M
Cap. Flow %
11.2%
Top 10 Hldgs %
65.7%
Holding
58
New
9
Increased
8
Reduced
26
Closed
9

Top Buys

1
NKTR icon
Nektar Therapeutics
NKTR
$60.1M
2
SAGE
Sage Therapeutics
SAGE
$38.6M
3
RCKT icon
Rocket Pharmaceuticals
RCKT
$28.5M
4
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$21.1M
5
TSRO
TESARO, Inc.
TSRO
$20M

Top Sells

1
JUNO
Juno Therapeutics, Inc.
JUNO
$25.1M
2
KA
Kineta, Inc. Common Stock
KA
$19.2M
3
ANAB icon
AnaptysBio
ANAB
$15.3M
4
BLUE
bluebird bio
BLUE
$14.2M
5
WVE icon
Wave Life Sciences
WVE
$7.09M

Sector Composition

1 Healthcare 96.5%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
RETA
26
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$9.23M 0.69%
450,000
+250,000
+125% +$5.13M
ACRS icon
27
Aclaris Therapeutics
ACRS
$223M
$9.21M 0.69%
525,538
-24,462
-4% -$429K
ABEO icon
28
Abeona Therapeutics
ABEO
$356M
$7.88M 0.59%
549,404
-25,596
-4% -$367K
BHVN
29
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$7.34M 0.55%
284,735
-13,068
-4% -$337K
COLL icon
30
Collegium Pharmaceutical
COLL
$1.25B
$7.32M 0.55%
286,668
-13,332
-4% -$341K
SGMO icon
31
Sangamo Therapeutics
SGMO
$161M
$7.26M 0.54%
382,192
-17,808
-4% -$338K
ZLAB icon
32
Zai Lab
ZLAB
$3.48B
$7.11M 0.53%
333,166
– –
KDMN
33
DELISTED
Kadmon Holdings, Inc.
KDMN
$7.01M 0.52%
+1,648,432
New +$7.01M
MTVA
34
MetaVia Inc. Common Stock
MTVA
$16.2M
$6.78M 0.51%
1,041,635
+241,635
+30% +$1.6M
CFRX
35
DELISTED
ContraFect Corporation
CFRX
$5.39M 0.4%
3,392,234
-157,766
-4% -$252K
HRTX icon
36
Heron Therapeutics
HRTX
$204M
$5.28M 0.39%
191,108
-8,892
-4% -$245K
SLDB icon
37
Solid Biosciences
SLDB
$448M
$5.14M 0.38%
+685,958
New +$5.14M
ARNA
38
DELISTED
Arena Pharmaceuticals Inc
ARNA
$4.94M 0.37%
+125,000
New +$4.94M
INDP icon
39
Indaptus Therapeutics
INDP
$5.98M
$4.89M 0.36%
773,816
-35,988
-4% -$241K
TRIL
40
DELISTED
Trillium Therapeutics Inc.
TRIL
$4.13M 0.31%
573,208
-26,792
-4% -$193K
NERV icon
41
Minerva Neurosciences
NERV
$16.8M
$3.8M 0.28%
607,903
– –
PTGX icon
42
Protagonist Therapeutics
PTGX
$3.62B
$3.28M 0.24%
382,139
-17,861
-4% -$153K
EOLS icon
43
Evolus
EOLS
$477M
$3.09M 0.23%
+342,400
New +$3.09M
XLRN
44
DELISTED
Acceleron Pharma Inc.
XLRN
$2.8M 0.21%
71,667
-3,333
-4% -$130K
JNCE
45
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1.86M 0.14%
82,988
-284,235
-77% -$6.35M
MRNS
46
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1.83M 0.14%
478,111
-21,889
-4% -$83.6K
ONSIZ
47
DELISTED
Oncobiologics, Inc. Series B Warrant
ONSIZ
$18K ﹤0.01%
416,666
– –
ONSIW
48
DELISTED
Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
$15K ﹤0.01%
416,666
– –
CLRBW
49
DELISTED
Cellectar Biosciences, Inc.
CLRBW
$6K ﹤0.01%
52,999
– –
OVID icon
50
Ovid Therapeutics
OVID
$94.6M
– –
-223,972
Closed -$2.21M
1
2
3